{"version":"1.0","type":"link","title":"Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China.","author_name":"Ye Q 외","author_url":"https://prs-insight.online/author/Ye%20Q","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/119668","thumbnail_width":1200,"thumbnail_height":630}